目的研究SOX4基因在前列腺癌患者中的表达;探讨二烯丙三硫(DATS)对SOX4表达阳性前列腺癌细胞的生物学作用及对SOX4表达的调节作用。方法采用免疫组织化学PV-9000二步法检测141例前列腺癌患者SOX4的表达,观察其与临床病理指标和预后的关联。采用不同浓度(0、20、40、60μmol/L)DATS处理前列腺癌Vcap细胞株,细胞增殖活性MTs法测定Vcap细胞的增殖能力;细胞体外侵袭实验检测40μmol/LDATs对Vcap细胞侵袭能力的作用;实时定量PCR(Real—timePCR)检测40μmol/LDATS作用后,Vcap细胞中SOX4mRNA的表达水平变化。结果SOX4蛋白在21%(28/135)的前列腺癌患者中过表达,与Gleason评分、远处转移呈正相关(P〈0.05)。SOX4是影响患者生存的独立预后因素。体外实验显示,20~60μmol/LDATs对前列腺癌细胞株Vcap的生长有较明显的抑制作用,且呈浓度和时间依赖性。40μmol/LDATs明显抑制Vcap细胞的侵袭能力,并在mRNA水平上下调SOX4的表达。结论SOX4的过表达提示前列腺癌患者预后不良。DATS抑制前列腺癌Vcap细胞的增殖和侵袭能力,并在mRNA水平上显著下调SOX4的表达。
Objective To characterize the expression of SOX4 in prostate cancer patients and investigate the effect of di- allyl trisulfide (DATS) on proliferation and invasion of SOX4-positive prostate cancer cells and its role in regulation of SOX4. Methods The PV9000 two-step immunohistochemical method was utilized to examine the expression of SOX4 protein in 141 prostate cancer patients. Correlation of SOX4 expression with clinicopathological parameters and progno- sis were also analyzed. Prostate cancer cell line Vcap, which demonstrated overexpression of SOX4, was treated with various concentrations of DATS (0,20,40,60 μmol/L), followed by MTS assay to determine its cellular proliferation; Matrigel invasion assay was used to assess the effect of 40 p.mol/L DATS on the invasive capacity of Vcap cells. Real time-PCR was performed to detect mRNA expression level of SOX4 by 40μmol/L DATS treatment. Results Overex- pression of SOX4 protein was preset in 21% (28/135) of prostate cancer patients, and significantly correlated with high Gleason score and the presence of distant metastasis ( P 〈 0.05 ). SOX4 was an independent prognostic factor for prostate